Biosynex S.A.
ALBIO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €18,503 | €89,475 | €116,879 | €224,311 |
| - Cash | €4,691 | €20,168 | €87,172 | €132,032 |
| + Debt | €62,457 | €65,598 | €52,068 | €35,311 |
| Enterprise Value | €76,269 | €134,905 | €81,775 | €127,590 |
| Revenue | €101,200 | €92,978 | €196,587 | €382,533 |
| % Growth | 8.8% | -52.7% | -48.6% | – |
| Gross Profit | -€20,000 | €49,132 | €64,520 | €182,553 |
| % Margin | -19.8% | 52.8% | 32.8% | 47.7% |
| EBITDA | -€17,826 | -€10,184 | €46,730 | €146,598 |
| % Margin | -17.6% | -11% | 23.8% | 38.3% |
| Net Income | -€43,300 | -€36,946 | €15,657 | €104,004 |
| % Margin | -42.8% | -39.7% | 8% | 27.2% |
| EPS Diluted | -3.32 | -2.85 | 1.26 | 8.27 |
| % Growth | -16.5% | -326.2% | -84.8% | – |
| Operating Cash Flow | -€10,121 | -€9,654 | €4,945 | €109,835 |
| Capital Expenditures | -€4,840 | -€39,544 | -€30,080 | -€19,015 |
| Free Cash Flow | -€14,961 | -€49,198 | -€25,135 | €90,819 |